Jab - Tissue Damage & Biomarkers for risk - Part 2

This is part 2 of a multi-part presentation on biomarkers that elevate in COVID and the JAB.

Dr Carter and I discuss biomarkers and the level of these markers that exacerbate risk of COVID, JAB, and chronic diseases.

Dr. Ryan Cole is the CEO and Medical Director of Cole Diagnostics, one of the largest independent labs in the State of Idaho. Dr. Cole is a Mayo Clinic trained Board Certified Pathologist.

He is Board Certified in anatomic and clinical pathology. He has expertise in immunology and virology and also has subspecialty expertise in skin pathology. He has seen over 350,000 patients in his career, and has done over 100,000 Covid tests in the past year.

He stresses that the best “mask” anyone could have is a healthy immune system, and he also emphasizes that there is absolutely no proven medical study that says masks need to be worn outside.

Dr. Cole explains the tremendous value of Vitamin D for all people, particularly for individuals who live above the 35th parallel and must supplement from Oct. through March. Dr. Cole also explains that obesity decreases a body’s ability to get the Vitamin D circulating to stimulate the immune system.

Established World Data: “Normal Vitamin D levels decrease COVID system severity and risk for hospitalization by up to 90%.”

Dr. Cole goes on to describe proven outpatient therapies that are being used successfully against COVID all over the world, and these therapies cost pennies compared to the costs of hospital treatments done in the United States.

He also makes very insightful remarks about the development of the COVID vaccines and discusses that in the U. S. a vaccine is not supposed to be approved if there are already successful outpatient treatments – which there are! One of these outpatient therapies has been shown to be successful for COVID-19 and for all variants.

Click below to see our video on biomarkers related to COVID and the "vaccine."